Search

CMS contracted Abt to conduct the 2022 Nursing Home Staffing Study, and our findings informed the agency’s 2024 staffing policy.

Abt Global has a long history of developing, monitoring, and reporting publicly on quality measures for CMS programs and care settings

Abt has extensive experience investigating and addressing the complex effects of per- and polyfluoroalkyl substances (PFAS) in the environment and on human health.

Abt Global implements evidence-based and high-impact service delivery projects that improve health outcomes for key, disadvantaged populations around the world.

Abt helped the EPA develop data-driven regulations, treatment tools, and exposure models that strengthen protections against contaminants such as PFAS and lead, improving drinking water safety for millions of Americans.

Abt uses machine learning to do things that until recently would have been impossible, such as categorizing a vast amount of unstructured text into main themes or counting mosquito eggs from a smartphone picture using image recognition.

Abt’s expertise with PFAS, lead, and perchlorate enables us to assess health risks, technology effectiveness, and health benefits of water treatment options.

For more than 25 years, Abt staff have been leaders and innovators in the NRDA field. We have assisted federal, state, and tribal natural resource agencies (who serve as trustees of natural resources on behalf of the public) with scientific, economic, legal, and strategic support on more than 150 NRDA cases around the country and in U.S. territories.

Abt Global is the world’s largest provider of interventions to track and control malaria, protecting millions of people annually in nearly 30 countries.